| Literature DB >> 21620486 |
Deane E Aikins1, Eric D Jackson, Alicia Christensen, Espen Walderhaug, Sonia Afroz, Alexander Neumeister.
Abstract
This pilot study tested whether posttraumatic stress disorder (PTSD) patients with impaired conditioned fear acquisition were refractory to open-label duloxetine treatment. Patients with a differential conditioned fear response at pre-treatment subsequently demonstrated significant reductions in PTSD symptoms. These data provide initial evidence of a putative biomarker of selective treatment response in PTSD. 2011 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21620486 DOI: 10.1016/j.psychres.2011.05.009
Source DB: PubMed Journal: Psychiatry Res ISSN: 0165-1781 Impact factor: 3.222